Trials & R&D · 11h ago Acadia falls after mid-stage trial setback for Alzheimer’s psychosis therapy 2 outlets Alzheimer's drugs
Trials & R&D · 12h ago Acadia slides on Phase 2 miss in Alzheimer’s psychosis but keeps moving asset forward 1 outlet Alzheimer's drugs